Login to Your Account



Cephalon Partners Cancer Program With Novuspharma

By Kim Coghill


Wednesday, May 8, 2002
In a three-year collaboration entered Tuesday with Cephalon Inc., Novuspharma SpA will use its preclinical research technology to screen a number of cancer compounds provided by Cephalon. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription